Sort
25,944 grants matching “neurodegeneration”
Genomic regulation of immune response in neurodegeneration in mice
$2,520,048Han-Yu Shih · National Eye Institute · ZIA · FY2025 · EY
Toward Personalized Prognosis and Outcomes in Primary Progressive Aphasia
$2,515,977Bradford C Dickerson · Massachusetts General Hospital · RF1 · FY2023 · NS
Postmortem Brain Tissue Examination in Neuropsychiatric Disorders
$2,511,813Joel Kleinman · National Institute Of Mental Health · ZIA · FY2009 · MH
Developing new tools for high throughput analysis of microcircuits and synapse ultrastructure using tagged vesicular transporters and deep learning.
$2,509,965Thomas Hnasko · University Of California, San Diego · RF1 · FY2019 · MH
In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies
$2,507,311Clotilde Lagier-Tourenne · Massachusetts General Hospital · RF1 · FY2021 · NS
INTERACTION OF SYNCLEIN AND INFLAMMATION IN DOPAMINERGIC NEURODEGENERATION
$2,506,750The Trustees Of Columbia University In The City Of New York · · FY2008 · Department of the Army
Proteostasis in Aging and Neurodegenerative Disease
$2,505,973Richard I. Morimoto · Northwestern University · P01 · FY2020 · AG
Modulation Of Neuronal Channels and Receptors in the Brain
$2,499,546Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Neuromodulation and Neurodegeneration: the Missing Link and Mechanisms of Action
$2,497,500Viviana Gradinaru · California Institute Of Technology · DP2 · FY2013 · NS
Proteopathies of the Aging Central Nervous
$2,495,388J. David Gladstone Institutes · P01 · FY2005 · AG
Alzheimer's Disease Research Center
$2,492,346University Of California San Diego · P50 · FY2005 · AG
Senescent cell mapping, identification and validation for human somatic and reproductive tissues
$2,492,316Judith Campisi · Buck Institute For Research On Aging · U54 · FY2022 · AG
Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD
$2,481,834Mark W Albers · Harvard Medical School · RF1 · FY2022 · AG
ALZHEIMERS DISEASE RESEARCH CENTER
$2,479,791University Of California San Diego · P50 · FY2000 · AG
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,479,625Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Federated Deep Learning to Accelerate Alzheimer's Disease Research
$2,477,877Paul M Thompson · University Of Southern California · RF1 · FY2025 · AG
Pharmaceutical Research Center
$2,477,561Henry Lewis · Florida Agricultural And Mechanical Univ · G12 · FY2008 · RR
Routes to enhanced HIV neuropathogenesis through expression of subclinical levels of endogenous amyloid-beta
$2,475,013David J Volsky · Icahn School Of Medicine At Mount Sinai · RF1 · FY2022 · NS
The POINTER Neurovascular Ancillary Study
$2,474,352Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2020 · AG
Elucidating factors that modulate tauopathy and cellular degeneration to guide therapeutic development
$2,473,595Jada M Lewis · University Of Florida · RF1 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)
$2,473,288Liana G Apostolova · Indiana University Indianapolis · U01 · FY2019 · AG
Postmortem Brain Tissue Examination in Neuropsychiatric Disorders
$2,470,190Joel Kleinman · National Institute Of Mental Health · ZIA · FY2012 · MH
Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimerâs disease pathophysiology
$2,466,001Stephen D. Ginsberg · New York University School Of Medicine · RF1 · FY2023 · AG
Discovery and validation of novel targets for pharmacotherapy of alcoholism
$2,465,593Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2010 · AA
Proteopathies of the Aging Central Nervous
$2,465,000Lennart Mucke · J. David Gladstone Institutes · P01 · FY2006 · AG